Biotechnology Six bispecific antibody companies you should know about Bispecific antibodies seem to be all the rage at the minute. Their ability to deliver targeted therapeutics to patients with a two-in-one approach by simultaneously binding to two different antigens or epitopes makes them an extremely attractive proposition to drug developers. This can be seen in the fact that there have been multiple big buyouts […] Written by Willow Shah-Neville November 20, 2024November 20, 2024 Saving Bookmark this article Bookmarked
Biotechnology Tetraspecific B/NK cell better than T cell engagers The therapeutic landscape for relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL) is evolving toward targeted T-cell based immunotherapies, including CD19-targeted CAR-T and CD3xCD20 T-cell engaging (TCE) bispecificantibodies. Yet, there remains an unmet medical need for patients who are refractory to, or ineligible for these treatments. Leveraging natural killer NK cells emerges as a promising […] Written by Thomas Gabrielczyk November 16, 2024November 16, 2024 Saving Bookmark this article Bookmarked
Biotechnology GSK partners with Flagship startup to hunt for Parkinson’s drugs Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for Parkinson’s and another neurodegenerative condition. Written by Gwendolyn Wu November 13, 2024November 13, 2024 Saving Bookmark this article Bookmarked
Biotechnology New tentative approval for Alembic drug dabigatran etexilate mesylate Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs. There are three patents protecting this compound. Drug patent litigation for DABIGATRAN ETEXILATE MESYLATE. Nine suppliers are […] Written by DrugPatentWatch – Make Better Decisions November 10, 2024November 10, 2024 Saving Bookmark this article Bookmarked
Biotechnology Tuberculosis research in 2024: the latest advancements According to a new World Health Organization (WHO) report released on October 29, 2024, tuberculosis (TB) replaced COVID-19 to become the top cause of infectious disease-related deaths in 2023, as a total of 1.25 million people died from it last year. Additionally, 8.2 million people were newly diagnosed, up from 7.5 million in 2022. TB […] Written by Willow Shah-Neville November 6, 2024November 6, 2024 Saving Bookmark this article Bookmarked
Biotechnology CEO and Chairman of the Executive Board Jonathan Dickinson brings extensive biotech and pharma experience to Marseille-based Innate Pharma. He comes from Incyte, where he served as Executive Vice President and General Manager Europe since 2016. Prior to that, he gained significant leadership experience through several senior positions at oncology focused ARIAD Pharmaceuticals and Bristol-Myers Squibb. This followed a distinguished 13-year tenure […] Written by Maren Kühr November 3, 2024November 3, 2024 Saving Bookmark this article Bookmarked
Biotechnology Novo takes big step toward ending Ozempic, Wegovy shortages All doses of the two drugs are now listed as available in the U.S., per an FDA database, although the company cautioned patients may still experience "variability" filling their prescriptions. Written by Ned Pagliarulo October 30, 2024October 30, 2024 Saving Bookmark this article Bookmarked
Biotechnology Which pharmaceutical companies have the most SPCs in Ireland? Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Ireland. SPCs are used in European Union and select others to encourage pharmaceutical innovation bycompensating for the long time needed to obtain regulatory approval for drugs. SPCscome into force only after the corresponding general […] Written by DrugPatentWatch – Make Better Decisions October 27, 2024October 27, 2024 Saving Bookmark this article Bookmarked
Biotechnology the race begins with first successful trial RNA editing has picked up steam in recent years as a potentially safer alternative to gene editing to treat genetic diseases. A study in humans was much anticipated, and Massachusetts-based Wave Life Sciences took the reins and began one last year. Now, Wave is the first to achieve RNA editing in the clinic, crossing yet […] Written by Roohi Mariam Peter October 24, 2024October 24, 2024 Saving Bookmark this article Bookmarked
Biotechnology SciVario® twin Bioprocess Controller: Addressing Current and Future Needs Regardless of your research area, the SciVario twin was designed as a flexible and future proof system able to control one or two of the same or different bioreactors individually or in parallel. The innovative bay-drawer concept enables modular adaption of the system, eliminating the need to purchase a whole new system in case of […] Written by Christian Kähler October 20, 2024October 20, 2024 Saving Bookmark this article Bookmarked
VU Researchers Publish Study on the Mechanism of CRISPR-Cas “Protein Scissors” in Molecular Cell CRISPR-Cas systems help to protect bacteria from viruses. Several different types of CRISPR-Cas defense systems are found in bacteria, which differ in their composition and functions. Among them, the most studied proteins today are Cas9 and Cas12, also known as DNA or gene ‘scissors’, which have revolutionized the field of genome editing, enabling scientists to […] Written by Elsevier Ltd, The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, United Kingdom November 19, 2024November 19, 2024 Saving Bookmark this article Bookmarked
Visualizing ER-phagy and ER architecture in vivo ER-phagy is an evolutionarily conserved mechanism crucial for maintaining cellular homeostasis. However, significant gaps persist in our understanding of how ER-phagy and the ER network vary across cell subtypes, tissues, and organs. Furthermore, the pathophysiological relevance of ER-phagy remains poorly elucidated. Addressing these questions requires developing quantifiable methods to visualize ER-phagy and ER architecture in […] Written by Admin November 19, 2024November 19, 2024 Saving Bookmark this article Bookmarked
VU Researchers Publish Study on the Mechanism of CRISPR-Cas “Protein Scissors” in Molecular Cell CRISPR-Cas systems help to protect bacteria from viruses. Several different types of CRISPR-Cas defense systems are found in bacteria, which differ in their composition and functions. Among them, the most studied proteins today are Cas9 and Cas12, also known as DNA or gene ‘scissors’, which have revolutionized the field of genome editing, enabling scientists to […] Written by Elsevier Ltd, The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, United Kingdom November 19, 2024November 19, 2024 Saving Bookmark this article Bookmarked
Visualizing ER-phagy and ER architecture in vivo ER-phagy is an evolutionarily conserved mechanism crucial for maintaining cellular homeostasis. However, significant gaps persist in our understanding of how ER-phagy and the ER network vary across cell subtypes, tissues, and organs. Furthermore, the pathophysiological relevance of ER-phagy remains poorly elucidated. Addressing these questions requires developing quantifiable methods to visualize ER-phagy and ER architecture in […] Written by Admin November 19, 2024November 19, 2024 Saving Bookmark this article Bookmarked
Workers and the just transition Some takes the form of an anti-environmental backlash, instigated or colonised by conservative and far-right forces. While posing as allies of “working families”, they denigrate the most fundamental of workers’ needs: for a habitable planet. Some takes a progressive form, the classic case being the gilets jaunes in France. When Emmanuel Macron’s government hiked “green […] Written by brendan November 19, 2024November 19, 2024 Saving Bookmark this article Bookmarked
Understanding PMDA Validation Rules v5.0 The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has always led the charge in ensuring the safety and efficacy of drug development. Their latest update, the PMDA Validation Rules version 5.0, which took effect on April 1, 2024, marks another significant step in this mission. Let’s break down what these new rules mean and […] Written by Admin July 10, 2024July 10, 2024 Saving Bookmark this article Bookmarked
Enhance Your SEND Submissions! Join PointCross on May 29th, 2024, at 12 PM EST / 9 AM PST for a must-attend webinar: The Most Common Issues in Preparing SEND. Ideal for professionals in data submission and regulatory compliance, this webinar offers valuable insights from our seasoned experts. Why Attend? Why PointCross? With over 10 years of experience and more […] Written by Admin May 23, 2024May 23, 2024 Saving Bookmark this article Bookmarked